267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford

Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

Episode metadata supplied by the publisher feed · Published Jul 20, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford

0:00 35:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 35 minutes long.

When was this The Readout Loud episode published?

This episode was published on July 20, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!